Scarica l'app Stockscreener
2.13
8.67%
0.17
Dopo l'orario di chiusura:
2.10
-0.03
-1.41%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.96
Aprire:
$1.97
Volume 24 ore:
1.45M
Relative Volume:
0.79
Capitalizzazione di mercato:
$141.70M
Reddito:
$488.00K
Utile/perdita netta:
$-41.44M
Rapporto P/E:
-2.2903
EPS:
-0.93
Flusso di cassa netto:
$-31.47M
1 W Prestazione:
+2.40%
1M Prestazione:
-15.14%
6M Prestazione:
-42.97%
1 anno Prestazione:
-2.74%
Intervallo 1D:
$1.96
$2.15
Intervallo di 1 settimana:
$1.90
$2.15
Portata 52W:
$1.90
$5.6395
Cardiff Oncology Inc Stock (CRDF) Company Profile
Nome
Cardiff Oncology Inc
Settore
Industria
Telefono
858-952-7570
Indirizzo
11055 FLINTKOTE AVENUE, SAN DIEGO, CA
Confronta CRDF con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRDF
Cardiff Oncology Inc
|
2.13 | 129.73M | 488.00K | -41.44M | -31.47M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Cardiff Oncology Inc Stock (CRDF) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-08 | Iniziato | Ladenburg Thalmann | Buy |
| 2025-06-24 | Iniziato | Jefferies | Hold |
| 2024-09-06 | Iniziato | Craig Hallum | Buy |
| 2022-01-05 | Iniziato | William Blair | Outperform |
| 2021-12-08 | Iniziato | Robert W. Baird | Outperform |
| 2021-08-09 | Ripresa | Maxim Group | Buy |
| 2020-10-22 | Iniziato | H.C. Wainwright | Buy |
| 2020-10-08 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Cardiff Oncology Inc Borsa (CRDF) Ultime notizie
How moving averages guide Cardiff Oncology Inc. trading2025 Fundamental Recap & Precise Trade Entry Recommendations - Newser
Regression analysis insights on Cardiff Oncology Inc. performanceTrade Volume Summary & Daily Stock Trend Watchlist - Newser
What moving averages say about Cardiff Oncology Inc.2025 Historical Comparison & AI Based Buy and Sell Signals - Newser
Will a bounce in Cardiff Oncology Inc. offer an exitRisk Management & Daily Profit Maximizing Tips - Newser
Will Cardiff Oncology Inc. rebound enough to break evenTrade Entry Summary & Low Volatility Stock Suggestions - Newser
What Fibonacci levels say about Cardiff Oncology Inc. rebound2025 Price Momentum & Verified Swing Trading Watchlists - Newser
Using data filters to optimize entry into Cardiff Oncology Inc.Quarterly Earnings Summary & High Yield Equity Trading Tips - Newser
Is Cardiff Oncology Inc. a play on infrastructure spending2025 Market WrapUp & Risk Controlled Swing Alerts - khodrobank.com
What institutional flow reveals about Cardiff Oncology Inc.Bond Market & Free Community Consensus Stock Picks - Newser
Signal strength of Cardiff Oncology Inc. stock in tech scannersWeekly Stock Report & Consistent Return Investment Signals - Newser
What is Cardiff Oncology Inc. s 5 year growth outlook2025 Bull vs Bear & Real-Time Price Movement Reports - khodrobank.com
What to do if you’re stuck in Cardiff Oncology Inc.Quarterly Portfolio Review & Risk Managed Investment Strategies - Newser
Best data tools to analyze Cardiff Oncology Inc. stock2025 Market Outlook & Community Supported Trade Ideas - Newser
How to build a custom watchlist for Cardiff Oncology Inc.July 2025 Pullbacks & Low Risk High Reward Ideas - Newser
Is Cardiff Oncology Inc. building a consolidation baseJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - Newser
Is Cardiff Oncology Inc. stock a growth or value playJuly 2025 Technicals & Real-Time Volume Analysis Alerts - Newser
Published on: 2025-09-02 00:18:09 - Newser
Is now a turning point for Cardiff Oncology Inc.Watch List & Real-Time Buy Signal Alerts - Newser
Is Cardiff Oncology Inc. stock poised for growthPortfolio Performance Summary & Expert Verified Movement Alerts - Newser
Will Cardiff Oncology Inc. benefit from current market trendsWeekly Profit Recap & Free Growth Oriented Trading Recommendations - khodrobank.com
Can Cardiff Oncology Inc. weather a recessionForecast Cut & AI Optimized Trading Strategy Guides - khodrobank.com
Forecasting Cardiff Oncology Inc. price range with options dataInsider Selling & Community Consensus Trade Alerts - Newser
Long term hold vs stop loss in Cardiff Oncology Inc.July 2025 Summary & Precise Trade Entry Recommendations - Newser
How Cardiff Oncology Inc. stock performs during market volatility2025 Growth vs Value & AI Enhanced Trading Signals - Newser
Has Cardiff Oncology Inc. formed a bullish divergence2025 Dividend Review & Weekly Top Performers Watchlists - Newser
Cardiff Oncology Inc. Price Holds Above Key Fib Level getLinesFromResByArray error: size == 0 - thegnnews.com
What high frequency data says about Cardiff Oncology Inc.Volume Spike & Weekly Watchlist of Top Performers - Newser
Can Cardiff Oncology Inc. recover in the next quarterJuly 2025 Short Interest & Low Risk High Win Rate Picks - Newser
Published on: 2025-08-30 11:40:38 - Newser
Price action breakdown for Cardiff Oncology Inc.Earnings Risk Report & Risk Managed Investment Entry Signals - Newser
What candlestick patterns are forming on Cardiff Oncology Inc.July 2025 Analyst Calls & Expert Approved Momentum Ideas - Newser
Will Cardiff Oncology Inc. price bounce be sustainableEarnings Recap Summary & High Conviction Buy Zone Picks - Newser
Why Cardiff Oncology Inc. is moving todayPortfolio Return Report & Fast Momentum Stock Entry Tips - Newser
Cardiff Oncology Inc Azioni (CRDF) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cardiff Oncology Inc Azioni (CRDF) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| PACE GARY W | Director |
Jul 30 '25 |
Buy |
2.45 |
15,000 |
36,750 |
1,345,676 |
| Levine James E. | Chief Financial Officer |
Dec 17 '24 |
Buy |
5.42 |
2,752 |
14,905 |
65,316 |
| Levine James E. | Chief Financial Officer |
Dec 18 '24 |
Buy |
5.00 |
2,400 |
12,000 |
67,716 |
| Levine James E. | Chief Financial Officer |
Dec 16 '24 |
Buy |
3.83 |
2,564 |
9,820 |
62,564 |
| TANNENBAUM RENEE P | Director |
Dec 12 '24 |
Buy |
3.42 |
10,000 |
34,224 |
20,000 |
| PACE GARY W | Director |
Dec 11 '24 |
Buy |
2.60 |
350,115 |
910,299 |
1,047,876 |
| PACE GARY W | Director |
Dec 11 '24 |
Buy |
2.60 |
11,500 |
29,900 |
1,059,376 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):